Investor Relations
Investor Relations Contact:
Anne Marie Fields
Bruce Voss

Media Contact
Rooney & Associates
Terry Rooney
Marion Janic

OPKO Health Enters into Exclusive Agreement with Japan Tobacco to Develop and Commercialize RAYALDEE® in Japan more »

OPKO's BioReference Laboratories and The Garage Announce National Strategic Affiliation to Enhance Value-Based Care more »

OPKO's GeneDx to Showcase Leadership in Genetic Testing at the National Society of Genetic Counselors and the American Society of Human Genetics Annual Meetings more »

OPKO Health to Present at Upcoming September Conferences more »

Investor FAQs

OPKO Health was incorporated in Delaware in 1991 as Cytoclonal Pharmaceutics, Inc.


The company expects to report the financial results for the fourth quarter 2016 on March 1, 2017. 

OPKO Health common stock is traded on the New York Stock Exchange under the symbol “OPK.”

The company’s most recent investor presentation is available in the “Investors” section on the company’s website. It can also be accessed at the “Events” page of the “Investors” section on the company’s website.

The fiscal year ends on December 31.


OPKO Health does not offer a direct stock purchase plan. Shares of the company can be purchased through a brokerage company.

OPKO Health, Inc. has never declared or paid cash dividends. The company intends to retain any future earnings for the operation and expansion of its business and does not anticipate paying any cash dividends in the foreseeable future.

The date and location will be published in the company’s proxy statement, which can be found on the “SEC Filings” section in the “Investors” section on the company’s website.

OPKO Health Corporate Headquarters
4400 Biscayne Blvd.

Miami, FL 33137

Tel: (305) 575-4100

American Stock Transfer & Trust Company, LLC,

6201 15th Ave.

Brooklyn, NY 11209
Toll-free at (877) 248-6417 or

(718) 921-8317

To replace lost stock certificates, please contact OPKO Health’s transfer agent

To change your address, please contact OPKO Health’s transfer agent.

For questions related to the exchange of BRLI shares for OPK shares, please contact OPKO Health’s transfer agent.


Please submit your question using the form below.

Please submit your question using the form below. * Required fields

This helps OPKO Health, Inc. prevent automated submissions.

Email  Sign up for email alerts